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Numerous multiple trauma and surgical patients suﬀer from accidental hypothermia. While induced hypothermia is commonly
used in elective cardiac surgery due to its protective eﬀects, accidental hypothermia is associated with increased posttraumatic
complications and even mortality in severely injured patients. This paper focuses on protective molecular mechanisms of
hypothermia on apoptosis and the posttraumatic immune response. Although information regarding severe trauma is limited,
there is evidence that induced hypothermia may have beneﬁcial eﬀects on the posttraumatic immune response as well as
apoptosis in animal studies and certain clinical situations. However, more profound knowledge of mechanisms is necessary before
randomized clinical trials in trauma patients can be initiated.
1.Introduction
A great number of patients with major injuries [1–3]s u f -
fer from accidental hypothermia ranging from 12 to 66%
[4, 5]. In the current literature, multiple classiﬁcations us-
ing diﬀerent deﬁnitions for hypothermia are described. In
mostclassiﬁcations,hypothermiaisdeﬁnedasacoretemper-
ature below 35◦C. Since an increase of mortality has been
demonstrated below a core temperature of 34◦Ci np a t i e n t s
with multiple injuries, this temperature threshold seems to
be critical in trauma patients and therefore a modiﬁed deﬁ-
nition is reasonable [6]. Thereby, the extent of hypothermia
correlates with the overall injury severity and is increased by
pelvic or abdominal surgery [7]; furthermore, hypothermic
polytrauma patients suﬀer from an increased incidence of
posttraumatic complications [2, 4, 8–10]a sw e l la saa ni n -
creased mortality [2, 8, 11].
Depending on its origin, three entities of hypothermia
are known: endogenous, induced, and accidental hypother-
mia.
Endogenous hypothermia results from a metabolic dys-
function with a decreased heat production (e.g., hypothyre-
odism, hypoglycaemia, hypoadrenalism) or a disturbed
thermoregulation (e.g., intracranial tumor, degenerative
neurologic disorders).
Accidental hypothermia is characterized by an uninten-
tional decrease of the core temperature due to exposure to
a cold environment without a thermoregulative dysfunction
[12]. This can be aggravated by therapeutic interventions.
The infusion of cold ﬂuids as, for example, 2 l of crystalloids
(18◦) decreases core temperatures about 0.6◦C[ 13]. In
addition, a reduced oxygen supply with an anaerobic state
decreases the amount of adenosine trisphosphate (ATP) and
subsequentheatproduction.Furthermore,theapplicationof
anaesthetics and skeletal muscle relaxants prevents shivering
and vasoconstriction and therefore advances heat loss.
While the ﬁrst two entities do not play a major role after
trauma, accidental hypothermia is common in trauma pa-
tients as well as patients undergoing major surgery [4, 5].
In contrast to accidental hypothermia that needs to be
addressed in the treatment of severely injured patients due
to its detrimental eﬀects, induced hypothermia is commonly
used, that is, in elective cardiac surgery [14]. In addition
there exists a strong recommendation for the induction
of hypothermia after cardiopulmonary reanimation, and2 Mediators of Inﬂammation
there exists a growing body of evidence that suggests the
application of hypothermia after blunt brain injury. Some
articles were published regarding the inﬂuence of hypother-
mia in context of elective surgery but also on the posttrau-
maticimmuneresponseinanimalmodels.However,anover-
view about the inﬂuence of hypothermia on the humeral and
cellular immune response with special focus on apoptosis is
missing. This paper outlines the molecular mechanisms by
which hypothermia inﬂuences apoptosis as well as the im-
mune response following severe trauma and major surgery.
2.Apoptosis
In general, cell death following hemorrhage and ischemia
occurs either as necrosis of aﬀected cells or as a complex pr-
ocess of programmed cell death called apoptosis. In contrast,
necrosis represents the premature death of cells caused by
external factors, that is, trauma, infections, or exposure to
toxins.
Apoptosis is associated with a cascade of enzymatic reac-
tions in which proteolytic caspase enzymes play a major role.
Apoptosis could be initiated either in an extrinsic or intrinsic
way [60]. The extrinsic way is characterized by the inter-
action of ligands (e.g., TNF-α)w i t h“ d e a t hr e c e p t o r s ”o nt h e
cell surface (e.g., CD95) activating the enzymatic cascade by
caspase-8 [61]. The intrinsic activation of apoptosis is trig-
gered by tumor suppressing factors (e.g., p53) resulting in
an increased expression of proapoptotic factors of the bcl-2
family(e.g.,bax,bad)andanincreasedmitochondrialrelease
of cytochrome-c [62]. Binding Apaf-1 (apoptotic protease
activating factor) cytochrome-c activates the apoptotic cas-
cade via caspase-9 [63, 64]. Finally, programmed cell death
is mediated by “eﬀector caspases,” especially caspase-3, in
both ways of apoptotic activation. Besides the proteins of
the bcl-2 family (antiapoptotic bcl-2; proapoptotic bax and
bad), the apoptotic process is regulated by Mitogen-acti-
vated protein kinases (MAP-kinases) like extracellular-
signal-regulated kinase 1/2 (ERK 1/2), cJun N-terminal pro-
teinkinase1/2(JNK1/2),andp38MAP-kinase.Additionally,
other pathways involving Phosphatidylinositol-3 kinases
(PI3K) generating phosphatidylinositol-3,4,5-trisphosphate
(PI-3,4,5-P(3)) and other phospholipids interacting with
Akt are known to play an important role in regulating cell
survival [65]. Furthermore, besides kinases the transcription
factorNF-kappaBregulatescellularapoptoticprograms[66].
In various studies, hypothermia was shown to prevent
additional tissue injury by interrupting both, the intrinsic,
and extrinsic apoptotic pathway [15, 67–70]. Interestingly,
hypothermia seems to aﬀect the very early steps in the apop-
totic process including inhibition of activation of caspase en-
zymes, preserving mitochondrial function and decreased
overload of excitatory transmitters. In contrast, apoptosis
occurs relatively late following tissue challenge but it was
shown that the process continues for up to 3 days [70–72].
Due to the delay of the apoptotic process, modulation of
the apoptotic cascade could serve as a therapeutic target
in early stages of polytrauma management after the initial
resuscitation process in which the patient is stabilized with
the aim to prevent additional damage. In this context, it is of
special importance that the rate of apoptosis in neutrophils
is dramatically decreased in multiple trauma patients [73].
2.1. In Vitro Studies. Cultured hepatocytes showed sup-
pressed FAS-mediated apoptosis detected by a decreased
mitochondrial damage following moderate hypothermia.
Besides an attenuated cytochrome-c release, hypothermia
suppressed the activation of caspase-7 and -9 [74]. This data
suggests potential organ protective eﬀects of hypothermia
regardingapoptosis,whichwereconﬁrmedinvariousanimal
models. On the other hand, murine neutrophils revealed a
reduced spontaneous and TNFα-induced apoptosis under
mild hypothermia of 35◦C[ 75]. This fact could result in
a prolonged exposure to activated neutrophils after trauma
resulting in secondary organ damage.
2.2. Experimental Animal and Clinical Studies. Profound hy-
pothermia was not only shown to preserve Akt in cardiomy-
ocytes and inhibit caspase-3 activation but also activate anti-
apoptotic proteins such as bcl-2 in an experimental model of
hemorrhagic shock [19] and ischemic insult [20]. In ische-
mia/reperfusion injury, hypothermia reversed activation of
apoptosisstimulatingfragment(FAS)/caspase-8,theincrease
of bax (an proapoptotic protein), and decrease of bcl-2 in
endothelialcells[16].Thiswasaccompaniedbyaninhibition
of JNK 1/2 activation via MKP-1 induction [16]. Following
ischemia and reperfusion, isolated cardiomyocytes showed
increased Phospho-Akt levels associated with attenuation of
reactive oxygen species production, which was blocked by
Akt but not cGMP inhibition [76]. Additionally, hypother-
mia was associated with downregulation of the TNF receptor
(TNFR)1 and its proapoptotic ligand FAS in rat cerebral cor-
tices following a moderate ﬂuid percussion model of trau-
matic brain injury [77].
Most of the clinical studies regarding the inﬂuence of hy-
pothermia on apoptosis are limited to ischemic injuries fol-
lowing cardiac arrest or brain ischemia [78, 79].
In summary, there is clear evidence that hypothermia
reduces ischemic neuronal apoptosis in global cerebral is-
chemiaasaresultofattenuatedp53expressionandincreased
bcl-2 release [78]. Information regarding multiple injuries is
notavailabletodate.Theeﬀectsofhypothermiaonapoptosis
are summarized in Table 1.
3. Immune System
3.1. Humoral Inﬂammatory Response. Immune response fol-
lowing major surgery or trauma consists of a complex set
of pro- and anti-inﬂammatory reactions in order to restore
homeostasis. The balance or imbalance of the pro- and anti-
inﬂammatory immune response in part inﬂuences the clini-
cal course. Whereas predominance of the pro-inﬂammatory
response leads to the Systemic Inﬂammatory Response Syn-
drome (SIRS), the anti-inﬂammatory reaction also named
as compensatory anti-inﬂammatory response syndrome
(CARS) might result in immune suppression with an en-
hanced risk of infectious complications. SIRS as well asMediators of Inﬂammation 3
Table 1: Eﬀects of hypothermia on apoptosis.
Authors Study design Insult Degree of
hypothermia Eﬀects
Xu et al. [15] In vitro study (mouse neurons) Apoptosis using serum
deprivation 33◦C caspase-3/8/9 ↓, cytochrome-c ↓,
JNK ↓ (no eﬀect on bcl-2, bax)
Yang et al. [16] In vitro study (HUVEC∗)
Ischemia using
oxygen-glucose
deprivation
33◦Cc a s p a s e - 3 / 8 ↓,b c l - 2↑,b a x↓,J N K↓
Pastuszko et al. [17] Experimental study (piglet neurons) Ischemia 33◦C caspase-3 ↓,b a x↓ (no eﬀect on
bcl-2)
Sahin et al. [18] Experimental study (rat neurons) Ischemia 34◦Cc a s p a s e - 3 / 9 ↓,b c l - 2↑,b a x↓
Shuja et al. [19] Experimental study (rat cardiac
tissue) Hemorrhage 15◦Cb c l - 2 ↑
Xiong et al. [20] Experimental study (rat neurons) Ischemia 32-33◦Cc a s p a s e - 3 ↓,b c l - 2↑
∗Human umbilical vein endothelial cells.
Table 2: Inﬂammatory cytokines.
Induction Synthesis Eﬀects
TNF-α hemorrhage, hypoxia, macrophages, monocytes, primary, proinﬂammatory cytokine
ischemia, endotoxine T-lymphocytes IL-1β and IL-6 expression
activation of coagulation
prostaglandine E2, steroid release
IL-1β hemorrhage, hypoxia, macrophages, monocytes, primary, pro-inﬂammatory cytokine
ischemia, endotoxine endothelial cells Synergistic eﬀects with TNF-α
C5a, TNF-α
IL-6 LPS, IL-1β,T N F - α T-/B-lymphocytes, Secondary, pro-inﬂammatory cytokine
monocytes, endothelial cells induction of acute phase proteins (e.g., CRP, PCT)
diﬀerentiation of lymphocytes
activation of von NK-cells and neutrophils
anti-inﬂammatory eﬀect (IL-1β ↓,T N F - α ↓)
IL-8 IL-1β,T N F - α, bacteria, T-lymphocytes, monocytes, Secondary, pro-inﬂammatory cytokine
LPS, hypoxia neutrophils, endothelial cells chemotactic eﬀect on leukocytes
IL-10 TNF-α,I L - 1 β, endotoxine, T-/B-lymphocytes, anti-inﬂammatory cytokine
LPS, prostaglandine E2 monocytes, macrophages
immune suppressionplaysa decisive rolein thedevelopment
of sepsis and the Multiple Organ Dysfunction Syndrome
(MODS) after trauma. Cytokines, released from various cell
types including immunocompetent and intrinsic cells, reg-
ulate the speciﬁc and unspeciﬁc immune response. These
mediators are detectable in the peripheral blood and several
compartments like the lung and the liver. They serve not
only as a marker of injury severity or outcome predictors
but also as a tool for decision-making regarding timing of
elective surgery during the clinical course [80, 81]. The most
important cytokines in this regard include TNF-α,I L - 1 β,I L -
6, IL-8, and IL-10 (Table 2). As another essential step of the
systemic immune response, chemotactic cytokines, so-called
chemokines (IL-8, MCP-1, MIP-1α,o rM I P - 1 β) mediate
neutrophil inﬁltration into the aﬀected tissue [82]. Thereby,
extravasation of neutrophils is mediated by diﬀerent adhe-
sion molecules [83]. The initial neutrophil-endothelial
interaction, so-called rolling, is mediated by members
of the selectin family of adhesion molecules. Integrins
(CD11/CD18) and immunoglobulin superfamily receptors
(ICAM-1, VCAM-1, ELAM-1) are important for the follow-
ing ﬁrm adhesion and cell diapedesis [84, 85]. In various
experimental as well as clinical studies, an eﬀect of hypother-
mia on the inﬂammatory response by altering the expression
of pro- and anti-inﬂammatory cytokines, chemokines and
adhesion molecules has been shown [38, 86–88].
In brain injury, cytokines can have neuroprotective
as well as neurotoxic properties. There is profound evi-
dence that an inadequate or disproportionate posttraumatic
immune response not only increases the risk for brain cell
injury but also the extent of damage [89–95]. In this process,
the IL-1 family plays a pivotal role. Elevated levels of IL-1 as
well as an increased expression of IL-1 mRNA were detected
following experimental brain injury in rodents, respectively
[96–100]. While IL-1 does not cause brain damage itself, in-
jection of IL-1 increased cell death following various brain4 Mediators of Inﬂammation
Table 3: Eﬀects of hypothermia on inﬂammatory cytokines.
Authors Study design Insult Degree of hypothermia Eﬀects
Zheng et al. [21] Experimental study (piglets) Ischemia 18◦CT N F - α ↓,I L - 6↓
Sipos et al. [22] Experimental study (pigs) Ischemia 19/24/30◦CN o e ﬀect TNF-α,I L - 6 ,I L - 1 0
Qing et al. [23] Experimental study (pigs) Ischemia 20/28◦CT N F - α ↓,I L - 1 0↑
Meybohm et al. [24] Experimental study (pigs) Ischemia 33◦CT N F - α ↓,I L - 1 β ↓,I L - 6↓,I L - 1 0↓
Su and Li [25] Experimental study (pigs) Ischemia Not deﬁned TNF-α ↓,I L - 6↓
Lim et al. [26] Experimental study (rats) Inﬂammation 27◦CI L - 1 β ↓,I L - 1 0↑
Fujimoto et al. [27] Experimental study (rats) Inﬂammation 32◦CI L - 6 ↓,I L - 1 0↑
Stewart et al. [28] Experimental study (mice) Inﬂammation 32◦C IL-6 ↑,I L - 1 0↑;n oe ﬀect on TNF-α,
IL-1β
Kim et al. [29] Experimental study (rats) Hemorrhage 27–30◦CI L - 6 ↓,I L - 1 0↑
Gundersen et al. [30] Experimental study (rats) Hemorrhage 32.5–33◦CI L - 6 ↓,n oe ﬀect on TNF-α,I L - 1 0
Beiser et al. [31] Experimental study (mice) Hemorrhage 33◦CI L - 6 ↓
Wagner et al. [32] Experimental study (mice) Septic shock 27◦CI L - 6 ↓
Vitarbo et al. [33] Experimental study (rats) Trauma (TBI) 33◦CT N F - α ↓
Morita et al. [34] Experimental study (rats) Trauma (Lung) 34◦CT N F - α ↓,I L - 6↓,I L - 1 0↑
Lee et al. [35] Experimental study (rats) Hypothermia
(isolated) 30◦CI L - 2 ↓,I L - 1 0↑
Qayumi et al. [36] Experimental study (pigs) Lung
transplantation
ex vivo preservation at
4◦C
No eﬀect on TNF-α,I L - 2 ,I L - 4 ,
IL-10, Thromboxan
Shiozaki et al. [37] Clinical study Trauma (TBI) 34◦CN o e ﬀect onTNF-α,I L - 6 ,I L - 1 0
Aibiki et al. [38] Clinical study Trauma (TBI) 32-33◦CI L - 6 ↓
damage models [101–103]. The hypothesis that IL-1 in-
creases brain damage is supported by experiments in which
anIL-1antagonistpreventedcelldeathinexperimentalbrain
injury [102–105]. Similar results were observed following
treatment with an IL-1 converting enzyme (ICE) inhibitor
in cerebral ischemia [106]. Thus, modulation of cytokine
release by hypothermia may serve as a therapeutic approach
following major injury.
3.1.1. In Vitro Studies. Peripheral blood mononuclear cells
stimulated with lipopolysaccharide (LPS) from healthy vol-
unteers showed decreased TNF-α release, while release of IL-
1 and IL-6 was delayed when incubated at 33◦Ca sc o m -
pared to incubation at 37◦C[ 86]. In a similar study with
human macrophages, early secretion of TNF-α and IL-6
was blunted and in human monocytes early IL-6 and IL-1β
secretion was decreased [107]. Additionally, a shift towards
anti-inﬂammatory cytokines was detected in microglia cells
following LPS treatment [108]. In contrast, hypothermia of
33◦C raised the levels of IL-1β,I L - 6 ,a n dT N F - α produced
by monocytes from healthy volunteers stimulated with LPS
[109]. This controversial ﬁndings suggest diverse eﬀects of
hypothermia on diﬀerent cell types.
3.1.2. Experimental Animal Models. In a rat model of
acute hemorrhage, Gundersen et al. evaluated the eﬀect of
hypothermia on immune response and corresponding organ
damage. Moderate hypothermia had an organ protective
eﬀect in liver and kidney, which was associated with a
decreased release of IL-6 as well as a reduction of reactive ox-
ygen species [30]. In contrast, mild hypothermia did not af-
fect systemic levels of IL-1, IL-6, and IL-10, while serum
TNF-α levels were even increased following hemorrhagic
shocksuggestingdiﬀerentresponsesofcytokinesortheirres-
pective sources [110].
In a study using a swine model of uncontrolled lethal
hemorrhage, the authors were able to detect a decreased pro-
inﬂammatory (IL-6) and an increased anti-inﬂammatory
(IL-10) immune response following profound hypothermia.
Furthermore, the potentially protective chaperone heat
shock protein-70 (HSP 70) was preserved. The authors,
therefore, concluded a beneﬁcial modulation of the immune
system due to hypothermia in this hemorrhage model [111].
Only a few publications investigated the anti-inﬂammat-
ory eﬀects of hypothermia in a combined trauma-hemor-
rhage setting. In a two-hit model consisting of a femoral
fracture and hemorrhage, systemic IL-10 levels were elevated
following mild hypothermia [44] conﬁrming results from
otherexperimentalstudies[35,112,113].Theincreasedanti-
inﬂammatory response induced by hypothermia was also
associatedwithaconversionfromTh-1toTh-2cytokinepat-
tern [35].
In a nonbacterial-driven sepsis model using intraperi-
toneal lipopolysaccharide injection, hypothermia also in-
duced elevated plasma IL-10 levels [114].
The eﬀects of hypothermia on the release of inﬂamma-
tory cytokines are presented in Table 3.
3.1.3. Clinical Studies. Experimental studies of traumatic
brain injury, in which hypothermia decreased systemicMediators of Inﬂammation 5
Table 4: Eﬀects of hypothermia on chemokines.
Authors Study design Insult Degree of hypothermia Eﬀects
Dalen et al. [39] In vitro study (human neurons)
Ischemia using
oxygen-glucose
deprivation
33◦C No eﬀect on IL-8,
MCP-1
Diestel et al. [40] In vitro study (HUVEC∗) Inﬂammation 17/32◦CI L - 8 ↓,M C P - 1↓
Sutcliﬀee ta l .[ 41] In vitro study (HCEC∗∗) Inﬂammation 32◦CI L - 8 ↓
Zheng et al. [21] Experimental study (piglets) Ischemia 18◦CI L - 8 ↓
Li et al. [42] Experimental study (rats) Ischemia 32-33◦CM C P - 1 ↓
Callaway et al. [43] Experimental study (rats) Ischemia 33◦C No eﬀect on MCP-1
and MIP-1α
Hildebrand et al. [44] Experimental study (mice) Hemorrhage 27–30/30–33/33–35◦CM C P - 1 ↓
Eggum et al. [45] Clinical study Surgery 25/32◦C RANTES and
MCP-1↓
Menasche et al. [46] Clinical study Surgery ∼26◦CN o e ﬀect on IL-8
∗human umbilical vein endothelial cells.
∗∗human cerebral endothelial cells.
Table 5: Eﬀects of hypothermia on adhesion molecules.
Authors Study design Insult Degree of hypothermia Eﬀects
Haddix et al. [47] In vitro study (HUVEC∗) Inﬂammation 25◦C E-Selectin ↓
Sutcliﬀee ta l .[ 41] In vitro study (HCEC∗∗) Inﬂammation 32◦C No eﬀect on ICAM-1, CD 18
(Integrin)
Frohlich et al. [48] In vitro study (human
leukocytes) Inﬂammation 33/35◦C CD 11b (Mac-1) ↑,n oe ﬀect on
CD62L (L-Selectin)
Johnson et al. [49] In vitro study (HUVEC∗) Hypothermia (isolated) 25◦C E-Selectin ↓
Meybohm et al. [24] Experimental study (pigs) Ischemia 33◦CI C A M - 1 ↓
Callaway et al. [43] Experimental study (rats) Ischemia 33◦CN o e ﬀect on ICAM-1
Wang et al. [50] Experimental (rats) Ischemia 33◦CI C A M - 1 ↓
Deng et al. [51] Experimental study (rats) Ischemia/Inﬂammation 33◦CI C A M - 1 ↓
Hanusch et al. [52] Experimental study (rats) Hypothermia (isolated)
Ex vivo storage after
ﬂushing lungs with cold
ﬂuid (4◦C)
ICAM-1 ↓,V C A M - 1↓,E L A M - 1
↓
Choi et al. [53] Experimental study (rats) Ischemia 33◦CI C A M - 1 ↓
Menasche et al. [46] Clinical study Surgery ∼26◦CN o e ﬀect on P- und E-Selectin
Boldt et al. [54] Clinical study Surgery 27-28◦C No eﬀect on ICAM-1, VCAM-1,
ELAM-1
∗human umbilical vein endothelial cells.
∗∗human cerebral endothelial cells.
cytokine levels, were conﬁrmed by a clinical study showing a
suppression in cytokine release associated with an improved
outcome [38, 88]. In cerebral trauma patients, hypothermia
of 32-33◦C suppressed systemic IL-6 levels, which was
associated with an increased Glasgow outcome scale 6
months postinjury as compared to patients treated under
normothermic conditions [38].
3.2. Adhesion Molecules and Chemokines. The eﬀects of
hypothermia on chemokine levels and the expression of
adhesion molecules were investigated in experimental as well
as clinical studies (Tables 4 and 5).
3.2.1. In Vitro Studies. In vitro studies of human umbilical
vein endothelial cells showed decreased MCP-1 as well as
IL-8 levels under hypothermic conditions [40]. In contrast,
no eﬀect of hypothermia on ICAM-1 expression in human
cerebral endothelial cells was shown under stress conditions
[41]. In cultured human umbilical vein cells, hypothermia
inhibited the transcription and expression but not the
induction of E-selectin [49].
3.2.2. Experimental Animal Models and Clinical Studies. In a
model of cerebral ischemia and reperfusion, mild hypother-
mia reduced local expression of MCP-1 [42] .T h es a m eﬁ n d -
ing could be conﬁrmed in a murine multiple trauma model
[44]. In another cerebral ischemia model, intraischemic as
well as delayed hypothermia decreased ICAM-1 expression
as well as intracerebral neutrophil inﬁltration [51].6 Mediators of Inﬂammation
In pediatric cardiopulmonary bypass (CPB) surgery,
hypothermia reduced systemic levels of the chemokine reg-
ulated on activation normal T cell expressed and secreted
(RANTES) and MCP-1 [45]. In contrast, no eﬀect of
hypothermia on MCP-1 levels was detected in a model of
cardiac arrest in rats [43].
In transient focal cerebral ischemia, mild hypothermia
reduced ICAM-1 expression, which was associated with
reduced neutrophil and monocyte inﬁltration [50].
In contrast to experimental studies, circulating adhesion
molecules were not altered by hypothermia in aortocoronary
artery bypass grafting [54]. The eﬀects of hypothermia on
adhesion molecules are presented in Table 5.
In summary, there is evidence that induced hypothermia
decreases pro-inﬂammatory cytokines as well as chemokines
and adhesion molecules. Besides this, an increased anti-in-
ﬂammatory cytokine response is observed in various trauma
models. However, information of human studies is spare.
3.3. Cellular Immune Response
3.3.1. Experimental Studies. Hypothermia inﬂuences the cel-
lular immune response, which was especially studied follow-
ing brain injury. In various animal models, neutrophil
and macrophage function was attenuated leading to a de-
creased extent of secondary brain injury and infarction size
[115]. Furthermore, posttraumatic hypothermia decreased
earlyandprolongedaccumulationofneutrophilsandmyelo-
peroxidase activity suggesting hypothermia as a potential
mechanism to modulate outcome [116]. These ﬁndings con-
ﬁrmed an earlier study of Toyoda et al. showing a decreased
neutrophil inﬁltration following intraischemic hypothermia
in a focal ischemia reperfusion injury [55], which was also
shown after delayed hypothermia in another cerebral ische-
mia model [51].
Additionally, posttraumatic hypothermia reduced neu-
trophil accumulation on the injury site at 24h in a model
of spinal cord injury [57].
Although most studies were conducted in traumatic
brain injury, similar ﬁndings were shown in other organs.
Already in the1980s, it wasshown thathypothermia reduced
local neutrophil inﬁltration in an experimental pleuritis mo-
del, while the number of circulating neutrophils was not af-
fected [117]. Other studies suggest a hypothermia-induced
decrease of circulating neutrophils after soft-tissue injury in
piglets [118], supporting an older study with prolonged hy-
pothermia of 29◦C in pigs [119]. The reduced inﬁltration
can be explained by a decrease of adhesion molecules due
to hypothermia. However, phagocytosis of opsonised bac-
teria is even increased at a lower temperature suggesting a
temperature-dependent activation of neutrophils [48].
Following major injuries, inﬁltrated neutrophils release
proteolytic enzymes as well as free radicals causing tissue
damage which may subsequently lead to organ dysfunction
and failure. Hypothermia was able to reduce the amount of
free radicals in ischemic brain injury. In contrast, hypother-
mia did not aﬀect the formation of free radicals in a rat
model of hemorrhagic shock [120–122]. The reduced num-
ber of free radicals is of great beneﬁt since the capacity of an-
tioxidative mechanisms is limited. Interestingly, the preven-
tion of free radical production is linearly linked to the tem-
perature [123]. Most of free radicals following brain injury
are synthesized by nitric oxide synthase and by deregulated
mitochondrial electron transporters [124–127]. Thus, it was
speculated that the prevention of release or synthesis of free
radicals may be induced by preserved mitochondrial func-
tion [128]. Interestingly, mitochondrial function plays also a
pivotal role in the development of apoptosis through inhibi-
tion of the caspase cascade activation. The essential role of
the nitric oxide synthase was supported by another experi-
ment, in which attenuation of acute lung injury by induced
hypothermia following hemorrhagic shock was associated
with less myeloperoxidase activity and decreased gene ex-
pression of iNOS. Furthermore, gene expression of heat
shock protein (HSP-72), a molecular chaperone known to
exert protective eﬀects in ischemia-reperfusion injury, was
detected in hypothermic but not in normothermic rats [29].
In contrast to these results, another study using a model
of pressure-controlled hemorrhagic shock revealed no dif-
ferences in serum-free 8-isoprostane (a marker of lipid pero-
xidation by free radicals) between the two groups at either
baselineorresuscitationtime1hr[120].Inaforebrainische-
mia and recirculation model, hypothermia prevented pro-
duction of hydroxyl radicals following hyperthermia [129].
In another study, postischemic leukotriene production a
well as edema development was reduced 2h but not 10min
following reperfusion [130]. The eﬀects of hypothermia on
the respiratory burst are summarized in Table 6.
3.3.2. Clinical Studies. Controlled mild hypothermia had no
eﬀectonthenumberofcirculatingTlymphocytesinpatients
with severe brain injury [131]. A clinical study including
infants and children with severe traumatic brain injury
showed a preserved antioxidant reserve in cerebrospinal
ﬂuid, suggesting an attenuation of oxidative stress following
hypothermia in severe brain injury [128].
4.FunctionalParameters
4.1. Experimental Studies. Less neuron damage was detected
atatemperatureof34◦Cfollowingbrainischemia[132]c on-
ﬁrming another study of thoracic aortic ischemia-reperfu-
sion injury in which hypothermia prevented and delayed
paralysis by preserving cells of the central nervous system
[133]. In another study, a beneﬁcial long-term eﬀect of mild
(35◦C) and moderate (32◦C) hypothermia was detected after
spinal cord ischemia and reperfusion until 28 days following
the injury [134].
Inaratmodelofischemia/reperfusionofthelowerextre-
mity,localhypothermiaprotectedskeletalmusclefromcapil-
lary leakage, which was prevented after treatment with heme
oxygenase and nitric oxide synthase inhibitors [135].
Hypothermia not only prevents damage on site of injury
butalsodistantorgandamage.Inmesentericischemia-reper-
fusion injury, remote lung injury was prevented as mea-
sured by leukocyte traﬃcking, alveolar hemorrhage, andMediators of Inﬂammation 7
Table 6: Eﬀects of hypothermia on proteins/molecules associated with the production of reactive oxygen species.
Authors Study design Insult Degree of hypothermia Eﬀects
Toyoda et al. [55] Experimental study (rats) Ischemia 30◦CM P O ↓
Lim et al. [26] Experimental study (rats) Inﬂammation 27◦CM P O ↓
Kim et al. [29] Experimental study (rats) Hemorrhage 27–30◦C
Malondialdehyde
(TBARS)↓,M P O↓,i N O S
↓,N O↓
Duz et al. [56] Experimental study (rats) Trauma (spinal cord) 27–29◦C Malondialdehyde (TBARS)
↓
Chatzipanteli et al. [57] Experimental study (rats) Trauma (spinal cord) 32◦CM P O ↓
Grezzana Filho et al. [58] Experimental study (rats) Ischemia 26◦C Malondialdehyde
(TBARS)↓,
Qayumi et al. [36] Experimental study (pigs) Lung transplantation ex vivo preservation at 4◦C
hypothermia)
No eﬀect on
Superoxide-Dismutase,
GR∗,G P ∗∗
Hsu et al. [59] Experimental study (rats) Heatstroke Perfusion with cold ﬂuid
(4◦C)
Malondialdehyde (TBARS)
↓ Glutathione ↑,G P ∗∗ ↑,
GR∗ ↑,
Superoxid-Dismutase ↑
Eggum et al. [45] Clinical study Surgery 25/32◦CN o e ﬀect on MPO
∗GR (Glutathione-Reduktase).
∗∗GP (Glutathione-Peroxidase).
∗∗∗GST (Glutathione-S-Transferase).
increasedBALproteinandwet/dryratios[136].Theseresults
conﬁrmed another study using a hepatic model of ische-
mia/reperfusion injury, in which hypothermia reduced the
associated lung injury [137].
In a rat hemorrhagic shock model, mild hypothermia
(34◦C) improved survival associated with modulation of the
immune response [110].
4.2. Clinical Studies. Clinical studies are mainly focused on
patients with traumatic brain injury. In general, there is a
gap between experimental studies and clinical experience.
In a multicenter study of 392 patients with severe head in-
juries, hypothermia of 33◦C did not inﬂuence outcome. In
5 meta-analyses, conﬂicting results regarding outcome were
shown [138–142]. Only 2 of them [141, 142]d e s c r i b e da
marginal beneﬁt regarding mortality and neurological out-
come. Patients with elevated intracranial pressure seem to be
the cohort with the most beneﬁt of hypothermia [141]. Re-
garding these controversial results, in current guidelines hy-
pothermia is recommended as a level III treatment option
[143].
5.CoolingRewarmingProcedure
5.1. Experimental Studies. Only few experimental studies in-
vestigated the eﬀect of diﬀerent cooling and rewarming
strategies.
Hypothermia at time of occlusion decreased infarct size
in a myocardial ischemia-reperfusion injury supporting the
results showing an increased cellular tolerance to ischemia
under hypothermic conditions [144]. These results suggest
starting hypothermia as soon as the hemodynamic and
hemostaseological parameters were stabilized. In contrast,
thereisconsistentevidencethatrapidrewarmingreversesthe
beneﬁcial eﬀects of induced hypothermia in traumatic brain
injury [145]. Furthermore, gradual rewarming improved
survival and attenuated remote acute lung injury after
intestinal ischemia and reperfusion injury as compared
to speed rewarming [146]. The mechanism behind this
phenomenon is only partly understood. Considering the
current literature, it seems likely that abrogation of the bene-
ﬁcial eﬀects is associated with ATP depletion, energy failure,
and consecutive mitochondrial dysfunction [145]. To date,
detailed knowledge about exact mechanisms in diﬀerent
rewarming strategies is lacking.
5.2. Clinical Studies. The European Resuscitation Council
recommends early hypothermia (32–34◦C) for 12–24 hours
following cardiac arrest and a slow rewarming procedure
with 0.25–0.5◦C per hour avoiding hyperthermia [147]. In a
clinical study in 57 hypothermic patients, continuous arteri-
ovenous rewarming resulted in less ﬂuid requirement and
less mortality as compared to standard rewarming proce-
dures [11].
Insummary,thereisonlyminorunderstandingofthere-
warming process but slow rewarming is recommended based
on mostly experimental studies.
6.Perspective
Beforeinducedhypothermiacanbeintroducedintheclinical
management of patients several limitations of the presented
studies need to be considered. A potential limitation of all
studies in which hypothermia is induced by a cardiopulmo-
narybypassmachineisthefactthatincreaseofcytokinesmay8 Mediators of Inﬂammation
be due to the bypass procedure itself [111]. While numer-
ous experimental as well as clinical studies regarding car-
diac surgery, brain injury, or cardiac arrest are available in-
formation regarding hypothermia following major injuries
is spare. Since there are still divergent results in experimental
studies that are mostly limited to traumatic brain injury, the
mechanisms by which hypothermia inﬂuences the posttrau-
matic immune response after multiple trauma need to be
elucidated.
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